Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02910180 · ClinicalTrials.gov registry record

Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders

A clinical trial of Ischemic Stroke and Cerebrovascular Diseases, sponsored by Cedars-Sinai Medical Center.

Recruiting
Registry status
900
Enrollment target
1
Study location

NCT02910180 is a study of Ischemic Stroke and Cerebrovascular Diseases that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 900 participants, below the 1,450-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02910180, a study of Ischemic Stroke and Cerebrovascular Diseases, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.

RECRUITING
Registry status
900 participants
Enrollment target
1
Study location

Study Summary

This study encompasses the maintenance and utilization of a repository of samples from patients with cerebrovascular disease and stroke. The types of tissue taken are blood, cerebrospinal fluid (CSF), tissue, and microdialysis samples. Future analysis of these samples can potentially help investigators to better categorize groups of patients, understand the underlying etiology of these pathologies, identify markers that are associated with favorable or poor outcomes, and track changes that occur during the natural course of the disease or with treatment. This is a prospective observational study which will use samples from such patients to create this library which can be used to explore these questions in the future.

Study Locations (1)

California

  • Cedars-Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2016-09
Est. Completion 2030-12

Sponsor

Cedars-Sinai Medical Center

339 total trials

What the Registry Record Tells You About NCT02910180

The ClinicalTrials.gov registry entry for NCT02910180 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,450-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (38% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT02910180 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02910180 about?

NCT02910180 is a clinical study titled "Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders". This study encompasses the maintenance and utilization of a repository of samples from patients with cerebrovascular disease and stroke. The types of tissue taken are blood, cerebrospinal fluid (CSF), tissue, and microdialysis samples. Future analysis of these samples can potentially help investigat...

What is the current status of trial NCT02910180?

This trial is currently recruiting. The enrollment target is 900 participants. The study started on 2016-09. Estimated completion is 2030-12.

What conditions does trial NCT02910180 study?

This clinical trial studies the following conditions: Ischemic Stroke, Cerebrovascular Diseases, Repository.

Who is sponsoring clinical trial NCT02910180?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02910180 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.